Jonathan M. Mansbach, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Bronchiolitis | 91 | 2024 | 458 | 14.900 |
Why?
|
| Respiratory Syncytial Virus Infections | 32 | 2023 | 329 | 5.920 |
Why?
|
| Bronchiolitis, Viral | 16 | 2021 | 74 | 4.370 |
Why?
|
| Rhinovirus | 25 | 2023 | 187 | 3.730 |
Why?
|
| Picornaviridae Infections | 15 | 2021 | 88 | 3.640 |
Why?
|
| Respiratory Sounds | 16 | 2021 | 696 | 3.000 |
Why?
|
| Respiratory Syncytial Virus, Human | 13 | 2023 | 139 | 2.990 |
Why?
|
| Respiratory Syncytial Viruses | 11 | 2020 | 165 | 2.590 |
Why?
|
| Nasopharynx | 21 | 2022 | 379 | 2.510 |
Why?
|
| Respiratory Tract Infections | 9 | 2022 | 961 | 2.200 |
Why?
|
| Hospitalization | 42 | 2024 | 10259 | 1.630 |
Why?
|
| Infant | 103 | 2023 | 35134 | 1.500 |
Why?
|
| Asthma | 25 | 2023 | 6010 | 1.370 |
Why?
|
| Nasal Cavity | 3 | 2018 | 313 | 1.020 |
Why?
|
| Moraxella | 5 | 2019 | 25 | 1.000 |
Why?
|
| Antimicrobial Cationic Peptides | 3 | 2017 | 362 | 1.000 |
Why?
|
| Length of Stay | 17 | 2020 | 6311 | 0.960 |
Why?
|
| Nasal Mucosa | 4 | 2019 | 373 | 0.930 |
Why?
|
| Croup | 1 | 2022 | 23 | 0.850 |
Why?
|
| Trachea | 2 | 2018 | 1076 | 0.820 |
Why?
|
| Haemophilus | 4 | 2019 | 27 | 0.810 |
Why?
|
| Common Cold | 5 | 2020 | 61 | 0.790 |
Why?
|
| RNA, Ribosomal, 16S | 5 | 2020 | 954 | 0.790 |
Why?
|
| Coronavirus | 2 | 2020 | 158 | 0.760 |
Why?
|
| Streptococcus | 3 | 2019 | 197 | 0.760 |
Why?
|
| Metabolome | 12 | 2021 | 895 | 0.730 |
Why?
|
| Apnea | 2 | 2019 | 195 | 0.720 |
Why?
|
| Erythema | 1 | 2021 | 257 | 0.710 |
Why?
|
| Bronchodilator Agents | 6 | 2018 | 502 | 0.700 |
Why?
|
| Child, Hospitalized | 1 | 2021 | 174 | 0.700 |
Why?
|
| Vitamin D Deficiency | 8 | 2018 | 1343 | 0.680 |
Why?
|
| Staphylococcus | 3 | 2018 | 155 | 0.680 |
Why?
|
| Vitamin D | 12 | 2023 | 3224 | 0.660 |
Why?
|
| Prospective Studies | 61 | 2023 | 53290 | 0.630 |
Why?
|
| Tracheostomy | 2 | 2018 | 401 | 0.620 |
Why?
|
| Emergency Service, Hospital | 14 | 2024 | 7658 | 0.610 |
Why?
|
| Biofilms | 1 | 2022 | 617 | 0.610 |
Why?
|
| Serum Albumin | 1 | 2019 | 675 | 0.550 |
Why?
|
| Viruses | 4 | 2023 | 375 | 0.530 |
Why?
|
| Infant, Premature, Diseases | 1 | 2021 | 707 | 0.520 |
Why?
|
| Critical Care | 7 | 2019 | 2647 | 0.490 |
Why?
|
| Child, Preschool | 32 | 2024 | 41005 | 0.490 |
Why?
|
| Pharynx | 2 | 2016 | 413 | 0.480 |
Why?
|
| Nasopharyngitis | 1 | 2013 | 10 | 0.480 |
Why?
|
| Aftercare | 1 | 2020 | 870 | 0.480 |
Why?
|
| Proteobacteria | 1 | 2013 | 45 | 0.470 |
Why?
|
| Severity of Illness Index | 23 | 2020 | 15535 | 0.470 |
Why?
|
| Depression, Postpartum | 1 | 2018 | 340 | 0.460 |
Why?
|
| Infant, Newborn | 27 | 2021 | 25628 | 0.430 |
Why?
|
| Humans | 127 | 2024 | 744366 | 0.410 |
Why?
|
| Climate | 1 | 2012 | 147 | 0.400 |
Why?
|
| Cross Infection | 1 | 2021 | 1417 | 0.400 |
Why?
|
| Male | 85 | 2023 | 350115 | 0.400 |
Why?
|
| Altitude | 1 | 2012 | 161 | 0.400 |
Why?
|
| L-Lactate Dehydrogenase | 1 | 2012 | 424 | 0.390 |
Why?
|
| Female | 86 | 2021 | 380193 | 0.380 |
Why?
|
| Respiratory System | 3 | 2022 | 557 | 0.360 |
Why?
|
| Haemophilus influenzae | 3 | 2022 | 172 | 0.360 |
Why?
|
| Patient Discharge | 4 | 2015 | 3318 | 0.350 |
Why?
|
| Continuous Positive Airway Pressure | 3 | 2017 | 546 | 0.350 |
Why?
|
| Child | 29 | 2024 | 77709 | 0.350 |
Why?
|
| Viral Load | 4 | 2021 | 3300 | 0.330 |
Why?
|
| Metapneumovirus | 1 | 2008 | 23 | 0.320 |
Why?
|
| Medical Staff, Hospital | 1 | 2012 | 601 | 0.300 |
Why?
|
| Cohort Studies | 26 | 2021 | 40559 | 0.300 |
Why?
|
| Sequence Analysis, DNA | 2 | 2018 | 4805 | 0.290 |
Why?
|
| Cathelicidins | 3 | 2017 | 80 | 0.290 |
Why?
|
| Multicenter Studies as Topic | 3 | 2019 | 1677 | 0.290 |
Why?
|
| Eczema | 2 | 2021 | 231 | 0.280 |
Why?
|
| Office Visits | 2 | 2010 | 598 | 0.280 |
Why?
|
| Feces | 3 | 2017 | 1401 | 0.280 |
Why?
|
| Ethics Committees, Research | 1 | 2007 | 194 | 0.260 |
Why?
|
| Molecular Typing | 3 | 2021 | 106 | 0.260 |
Why?
|
| Spermatic Cord Torsion | 1 | 2005 | 73 | 0.260 |
Why?
|
| Pneumonia, Viral | 2 | 2020 | 3242 | 0.260 |
Why?
|
| Intensive Care Units | 7 | 2020 | 3680 | 0.250 |
Why?
|
| United States | 35 | 2024 | 69872 | 0.250 |
Why?
|
| Urinary Tract Infections | 2 | 2021 | 788 | 0.250 |
Why?
|
| Influenza A virus | 1 | 2008 | 456 | 0.240 |
Why?
|
| Intubation, Intratracheal | 1 | 2012 | 1364 | 0.240 |
Why?
|
| Risk Factors | 23 | 2022 | 72296 | 0.240 |
Why?
|
| Oseltamivir | 1 | 2024 | 75 | 0.230 |
Why?
|
| Pandemics | 2 | 2020 | 8385 | 0.230 |
Why?
|
| Orchiectomy | 1 | 2005 | 474 | 0.230 |
Why?
|
| Emergency Medicine | 3 | 2012 | 1205 | 0.220 |
Why?
|
| Metabolic Networks and Pathways | 2 | 2018 | 783 | 0.220 |
Why?
|
| Recurrence | 6 | 2021 | 8340 | 0.220 |
Why?
|
| Antiviral Agents | 4 | 2024 | 2987 | 0.220 |
Why?
|
| Immunoglobulin E | 4 | 2023 | 1463 | 0.220 |
Why?
|
| Albuterol | 2 | 2018 | 208 | 0.220 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 3135 | 0.210 |
Why?
|
| Incidence | 9 | 2021 | 20952 | 0.210 |
Why?
|
| Hospitals, Psychiatric | 1 | 2003 | 332 | 0.200 |
Why?
|
| Child Health Services | 1 | 2007 | 667 | 0.200 |
Why?
|
| Clinical Protocols | 1 | 2007 | 1461 | 0.190 |
Why?
|
| Chemokine CCL5 | 2 | 2018 | 209 | 0.190 |
Why?
|
| Blood Sedimentation | 1 | 2021 | 231 | 0.190 |
Why?
|
| Sphingolipids | 2 | 2020 | 159 | 0.180 |
Why?
|
| Optic Nerve Diseases | 1 | 2003 | 327 | 0.180 |
Why?
|
| Streptococcus pneumoniae | 3 | 2022 | 714 | 0.180 |
Why?
|
| Multivariate Analysis | 10 | 2018 | 12244 | 0.180 |
Why?
|
| Health Care Surveys | 5 | 2024 | 2453 | 0.180 |
Why?
|
| Endemic Diseases | 1 | 2020 | 182 | 0.170 |
Why?
|
| Coxsackievirus Infections | 1 | 2019 | 44 | 0.170 |
Why?
|
| Cellulitis | 1 | 2020 | 206 | 0.170 |
Why?
|
| Enterovirus | 1 | 2019 | 64 | 0.170 |
Why?
|
| Hospitals, Pediatric | 4 | 2020 | 1775 | 0.160 |
Why?
|
| Ambulatory Care | 3 | 2015 | 2708 | 0.160 |
Why?
|
| Seasons | 4 | 2019 | 1493 | 0.160 |
Why?
|
| Nose | 1 | 2021 | 509 | 0.160 |
Why?
|
| Environmental Exposure | 1 | 2012 | 4232 | 0.160 |
Why?
|
| Lyme Disease | 1 | 2003 | 621 | 0.150 |
Why?
|
| Vesico-Ureteral Reflux | 1 | 2021 | 427 | 0.150 |
Why?
|
| Time Factors | 4 | 2020 | 40075 | 0.150 |
Why?
|
| Respiratory Hypersensitivity | 1 | 2019 | 274 | 0.150 |
Why?
|
| Virus Diseases | 2 | 2015 | 711 | 0.150 |
Why?
|
| Logistic Models | 8 | 2015 | 13409 | 0.150 |
Why?
|
| Finland | 4 | 2021 | 602 | 0.140 |
Why?
|
| DNA, Ribosomal | 1 | 2018 | 290 | 0.140 |
Why?
|
| Guideline Adherence | 1 | 2007 | 2265 | 0.140 |
Why?
|
| Age Distribution | 3 | 2008 | 2902 | 0.140 |
Why?
|
| Practice Guidelines as Topic | 2 | 2018 | 7282 | 0.140 |
Why?
|
| Metabolomics | 3 | 2020 | 1485 | 0.130 |
Why?
|
| Headache | 1 | 2003 | 1226 | 0.130 |
Why?
|
| Bordetella pertussis | 1 | 2015 | 43 | 0.130 |
Why?
|
| Phenobarbital | 1 | 1996 | 193 | 0.130 |
Why?
|
| Intensive Care Units, Pediatric | 2 | 2019 | 981 | 0.130 |
Why?
|
| Treatment Outcome | 11 | 2020 | 63107 | 0.130 |
Why?
|
| Pediatrics | 2 | 2007 | 3475 | 0.130 |
Why?
|
| Disease | 1 | 2020 | 680 | 0.130 |
Why?
|
| Polymerase Chain Reaction | 3 | 2015 | 6171 | 0.130 |
Why?
|
| Liver Neoplasms, Experimental | 1 | 1996 | 191 | 0.130 |
Why?
|
| Whooping Cough | 1 | 2015 | 82 | 0.120 |
Why?
|
| Statistics, Nonparametric | 1 | 2020 | 2887 | 0.120 |
Why?
|
| Longitudinal Studies | 3 | 2020 | 13991 | 0.120 |
Why?
|
| Receptors, Transforming Growth Factor beta | 1 | 1996 | 314 | 0.120 |
Why?
|
| Blood Proteins | 1 | 2019 | 1124 | 0.120 |
Why?
|
| Nonprescription Drugs | 1 | 2015 | 116 | 0.120 |
Why?
|
| Geography | 2 | 2007 | 669 | 0.120 |
Why?
|
| Saline Solution, Hypertonic | 1 | 2014 | 110 | 0.120 |
Why?
|
| Adrenal Cortex Hormones | 3 | 2014 | 1856 | 0.120 |
Why?
|
| Gastroesophageal Reflux | 1 | 2020 | 782 | 0.110 |
Why?
|
| Carcinogens | 1 | 1996 | 466 | 0.110 |
Why?
|
| Snow | 1 | 2012 | 16 | 0.110 |
Why?
|
| Gestational Age | 1 | 2021 | 3493 | 0.110 |
Why?
|
| DNA, Bacterial | 1 | 2018 | 1465 | 0.110 |
Why?
|
| Wind | 1 | 2012 | 38 | 0.110 |
Why?
|
| Rain | 1 | 2012 | 61 | 0.110 |
Why?
|
| Patient Admission | 3 | 2010 | 1380 | 0.110 |
Why?
|
| Influenza, Human | 1 | 2024 | 1479 | 0.110 |
Why?
|
| Hyponatremia | 1 | 2015 | 298 | 0.110 |
Why?
|
| Siblings | 1 | 2016 | 854 | 0.100 |
Why?
|
| Food Hypersensitivity | 1 | 2019 | 622 | 0.100 |
Why?
|
| Infant, Premature | 1 | 2021 | 2045 | 0.100 |
Why?
|
| Confidence Intervals | 3 | 2010 | 2971 | 0.100 |
Why?
|
| Proportional Hazards Models | 3 | 2021 | 12356 | 0.100 |
Why?
|
| Cytokines | 3 | 2019 | 7323 | 0.100 |
Why?
|
| Humidity | 1 | 2012 | 197 | 0.100 |
Why?
|
| Social Behavior | 1 | 2018 | 1127 | 0.100 |
Why?
|
| Prenatal Exposure Delayed Effects | 2 | 2015 | 2408 | 0.100 |
Why?
|
| Respiration, Artificial | 4 | 2015 | 2569 | 0.100 |
Why?
|
| Antibodies, Monoclonal | 2 | 2015 | 9274 | 0.100 |
Why?
|
| Adolescent | 11 | 2018 | 85779 | 0.100 |
Why?
|
| Cough | 1 | 2015 | 555 | 0.100 |
Why?
|
| Sex Distribution | 2 | 2008 | 2297 | 0.100 |
Why?
|
| Acute Disease | 2 | 2019 | 7147 | 0.100 |
Why?
|
| Hospital Charges | 1 | 2013 | 362 | 0.100 |
Why?
|
| Prevalence | 4 | 2020 | 15221 | 0.100 |
Why?
|
| Research Design | 1 | 2007 | 5984 | 0.100 |
Why?
|
| Risk Assessment | 4 | 2020 | 23336 | 0.100 |
Why?
|
| Follow-Up Studies | 6 | 2020 | 39052 | 0.090 |
Why?
|
| Positive-Pressure Respiration | 3 | 2020 | 633 | 0.090 |
Why?
|
| Epinephrine | 1 | 2014 | 792 | 0.090 |
Why?
|
| Retrospective Studies | 8 | 2024 | 77460 | 0.090 |
Why?
|
| Antibiotic Prophylaxis | 1 | 2015 | 639 | 0.090 |
Why?
|
| Cross-Sectional Studies | 8 | 2019 | 25039 | 0.090 |
Why?
|
| Anti-Bacterial Agents | 4 | 2014 | 7182 | 0.090 |
Why?
|
| Tobacco Smoke Pollution | 1 | 2015 | 816 | 0.090 |
Why?
|
| Statistics as Topic | 2 | 2014 | 2373 | 0.090 |
Why?
|
| C-Reactive Protein | 1 | 2021 | 3778 | 0.090 |
Why?
|
| Bacterial Infections | 1 | 2017 | 1401 | 0.080 |
Why?
|
| NF-kappa B | 1 | 2018 | 2499 | 0.080 |
Why?
|
| Prevotella | 2 | 2020 | 79 | 0.080 |
Why?
|
| Smoking | 3 | 2015 | 8987 | 0.080 |
Why?
|
| Pregnancy Complications | 2 | 2015 | 2861 | 0.080 |
Why?
|
| Drug Utilization | 2 | 2012 | 1183 | 0.080 |
Why?
|
| Models, Statistical | 2 | 2020 | 5101 | 0.080 |
Why?
|
| Tennessee | 1 | 2008 | 117 | 0.080 |
Why?
|
| Models, Theoretical | 1 | 2020 | 3589 | 0.080 |
Why?
|
| Forced Expiratory Volume | 2 | 2023 | 1745 | 0.080 |
Why?
|
| Bacteria | 1 | 2018 | 2115 | 0.080 |
Why?
|
| Massachusetts | 1 | 2020 | 8662 | 0.080 |
Why?
|
| Communicable Diseases | 1 | 2016 | 880 | 0.080 |
Why?
|
| Proteome | 3 | 2022 | 1798 | 0.070 |
Why?
|
| Health Surveys | 2 | 2009 | 4036 | 0.070 |
Why?
|
| Disease Management | 3 | 2014 | 2460 | 0.070 |
Why?
|
| Parents | 1 | 2020 | 3405 | 0.070 |
Why?
|
| Health Insurance Portability and Accountability Act | 1 | 2007 | 99 | 0.070 |
Why?
|
| Appointments and Schedules | 1 | 2010 | 417 | 0.070 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2018 | 3595 | 0.070 |
Why?
|
| Drug Utilization Review | 1 | 2007 | 245 | 0.070 |
Why?
|
| RNA, Viral | 1 | 2014 | 2901 | 0.070 |
Why?
|
| Probability | 2 | 2010 | 2506 | 0.070 |
Why?
|
| Temperature | 1 | 2012 | 2204 | 0.070 |
Why?
|
| Causality | 1 | 2012 | 1275 | 0.070 |
Why?
|
| Workplace | 1 | 2012 | 836 | 0.070 |
Why?
|
| Young Adult | 6 | 2018 | 56429 | 0.070 |
Why?
|
| Insurance, Health | 2 | 2010 | 2494 | 0.070 |
Why?
|
| Interviews as Topic | 2 | 2009 | 2539 | 0.070 |
Why?
|
| Parathyroid Hormone | 1 | 2012 | 1800 | 0.060 |
Why?
|
| Fatty Acids | 2 | 2023 | 1809 | 0.060 |
Why?
|
| Age Factors | 6 | 2020 | 18373 | 0.060 |
Why?
|
| Glucocorticoids | 1 | 2014 | 2108 | 0.060 |
Why?
|
| Hospitals, County | 1 | 2003 | 17 | 0.060 |
Why?
|
| Neuraminidase | 1 | 2024 | 210 | 0.060 |
Why?
|
| Adrenergic beta-Agonists | 1 | 2005 | 346 | 0.060 |
Why?
|
| Mental Disorders | 1 | 2003 | 6598 | 0.060 |
Why?
|
| Disease Susceptibility | 2 | 2020 | 1782 | 0.050 |
Why?
|
| Leukocytosis | 1 | 2003 | 247 | 0.050 |
Why?
|
| MicroRNAs | 1 | 2018 | 3751 | 0.050 |
Why?
|
| Intracranial Pressure | 1 | 2003 | 326 | 0.050 |
Why?
|
| Premature Birth | 1 | 2013 | 1721 | 0.050 |
Why?
|
| Lipid Metabolism | 2 | 2020 | 1889 | 0.050 |
Why?
|
| Prognosis | 3 | 2015 | 29060 | 0.050 |
Why?
|
| Predictive Value of Tests | 3 | 2020 | 15078 | 0.050 |
Why?
|
| Nausea | 1 | 2003 | 674 | 0.050 |
Why?
|
| Diagnosis, Differential | 1 | 2016 | 12961 | 0.050 |
Why?
|
| Vomiting | 1 | 2003 | 637 | 0.050 |
Why?
|
| Vital Capacity | 1 | 2023 | 925 | 0.050 |
Why?
|
| Pregnancy | 4 | 2020 | 29144 | 0.050 |
Why?
|
| Pneumonia | 1 | 2012 | 2133 | 0.050 |
Why?
|
| Cluster Analysis | 2 | 2017 | 2715 | 0.040 |
Why?
|
| Radiography | 2 | 2014 | 7023 | 0.040 |
Why?
|
| Anorexia Nervosa | 1 | 2008 | 1286 | 0.040 |
Why?
|
| Quality Indicators, Health Care | 1 | 2009 | 1831 | 0.040 |
Why?
|
| Respiratory Function Tests | 1 | 2023 | 1617 | 0.040 |
Why?
|
| Carnitine | 1 | 2020 | 246 | 0.040 |
Why?
|
| Insurance Coverage | 1 | 2010 | 1900 | 0.040 |
Why?
|
| Boston | 1 | 2012 | 9312 | 0.040 |
Why?
|
| Odds Ratio | 3 | 2016 | 9849 | 0.040 |
Why?
|
| Adult | 7 | 2017 | 214052 | 0.040 |
Why?
|
| Calcium | 1 | 2012 | 5755 | 0.040 |
Why?
|
| Host-Pathogen Interactions | 2 | 2019 | 1480 | 0.040 |
Why?
|
| Decision Trees | 1 | 2020 | 506 | 0.040 |
Why?
|
| Health Care Costs | 2 | 2013 | 3208 | 0.040 |
Why?
|
| Corynebacterium | 1 | 2017 | 47 | 0.040 |
Why?
|
| Interferon-alpha | 1 | 2022 | 895 | 0.040 |
Why?
|
| Gene Expression Regulation, Viral | 1 | 2020 | 442 | 0.040 |
Why?
|
| Poisson Distribution | 1 | 2018 | 513 | 0.040 |
Why?
|
| Diethylnitrosamine | 1 | 1996 | 38 | 0.030 |
Why?
|
| Expectorants | 1 | 2015 | 16 | 0.030 |
Why?
|
| Regression Analysis | 2 | 2020 | 6459 | 0.030 |
Why?
|
| Mycoplasma pneumoniae | 1 | 2015 | 43 | 0.030 |
Why?
|
| Antitussive Agents | 1 | 2015 | 17 | 0.030 |
Why?
|
| Nasal Decongestants | 1 | 2015 | 28 | 0.030 |
Why?
|
| Safety-Based Drug Withdrawals | 1 | 2015 | 38 | 0.030 |
Why?
|
| Case-Control Studies | 3 | 2017 | 21748 | 0.030 |
Why?
|
| Population Surveillance | 1 | 2005 | 2616 | 0.030 |
Why?
|
| Intubation | 1 | 2015 | 141 | 0.030 |
Why?
|
| Rats, Inbred F344 | 1 | 1996 | 862 | 0.030 |
Why?
|
| High-Frequency Ventilation | 1 | 2015 | 87 | 0.030 |
Why?
|
| Lung | 2 | 2023 | 9857 | 0.030 |
Why?
|
| Vitamins | 1 | 2023 | 1623 | 0.030 |
Why?
|
| Multilevel Analysis | 1 | 2014 | 142 | 0.030 |
Why?
|
| Fever | 1 | 2021 | 1616 | 0.030 |
Why?
|
| Blood Cell Count | 1 | 2014 | 403 | 0.030 |
Why?
|
| Gene Expression Regulation, Bacterial | 1 | 2020 | 1122 | 0.030 |
Why?
|
| Enzyme Inhibitors | 1 | 2024 | 3799 | 0.030 |
Why?
|
| Gene Expression Profiling | 2 | 2020 | 9445 | 0.030 |
Why?
|
| Nutrition Surveys | 2 | 2010 | 1660 | 0.030 |
Why?
|
| Lipids | 1 | 2023 | 3307 | 0.030 |
Why?
|
| Disease Progression | 2 | 2019 | 13286 | 0.030 |
Why?
|
| Mental Health Services | 1 | 2003 | 1644 | 0.030 |
Why?
|
| Utilization Review | 1 | 2013 | 392 | 0.020 |
Why?
|
| Emergency Medical Services | 1 | 2003 | 1917 | 0.020 |
Why?
|
| Pre-Eclampsia | 1 | 2020 | 1200 | 0.020 |
Why?
|
| Catheterization, Peripheral | 1 | 2014 | 345 | 0.020 |
Why?
|
| Specimen Handling | 1 | 2015 | 694 | 0.020 |
Why?
|
| Hospitals, Community | 1 | 2013 | 347 | 0.020 |
Why?
|
| Infant, Low Birth Weight | 1 | 2015 | 850 | 0.020 |
Why?
|
| Hospital Costs | 1 | 2016 | 985 | 0.020 |
Why?
|
| Proteomics | 1 | 2022 | 3638 | 0.020 |
Why?
|
| Chronic Disease | 1 | 2003 | 9145 | 0.020 |
Why?
|
| Socioeconomic Factors | 2 | 2014 | 7785 | 0.020 |
Why?
|
| Base Sequence | 1 | 2020 | 12797 | 0.020 |
Why?
|
| Community-Acquired Infections | 1 | 2012 | 465 | 0.020 |
Why?
|
| Radiography, Thoracic | 1 | 2014 | 1265 | 0.020 |
Why?
|
| Gene Expression | 1 | 2021 | 7798 | 0.020 |
Why?
|
| Patient Transfer | 1 | 2015 | 762 | 0.020 |
Why?
|
| Administration, Inhalation | 1 | 2010 | 1105 | 0.020 |
Why?
|
| United States Food and Drug Administration | 1 | 2015 | 1584 | 0.020 |
Why?
|
| Risk | 1 | 2019 | 9688 | 0.020 |
Why?
|
| Pilot Projects | 1 | 2020 | 8319 | 0.020 |
Why?
|
| Healthcare Disparities | 1 | 2022 | 3154 | 0.020 |
Why?
|
| Software | 1 | 2020 | 4441 | 0.020 |
Why?
|
| Phenotype | 1 | 2023 | 16367 | 0.020 |
Why?
|
| Medically Uninsured | 1 | 2010 | 853 | 0.020 |
Why?
|
| North America | 1 | 2008 | 1249 | 0.020 |
Why?
|
| Mothers | 1 | 2015 | 2165 | 0.020 |
Why?
|
| Emergencies | 1 | 2010 | 1170 | 0.010 |
Why?
|
| Survival Analysis | 1 | 2016 | 10252 | 0.010 |
Why?
|
| Chi-Square Distribution | 1 | 2008 | 3508 | 0.010 |
Why?
|
| Costs and Cost Analysis | 1 | 2006 | 1680 | 0.010 |
Why?
|
| RNA, Messenger | 1 | 1996 | 13035 | 0.010 |
Why?
|
| Sensitivity and Specificity | 1 | 2015 | 14723 | 0.010 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2021 | 17446 | 0.010 |
Why?
|
| Gene Expression Regulation | 1 | 2018 | 12073 | 0.010 |
Why?
|
| Rats | 1 | 1996 | 24252 | 0.010 |
Why?
|
| Data Interpretation, Statistical | 1 | 2009 | 2716 | 0.010 |
Why?
|
| Reproducibility of Results | 1 | 2015 | 19905 | 0.010 |
Why?
|
| Dietary Supplements | 1 | 2010 | 3296 | 0.010 |
Why?
|
| Immunity, Innate | 1 | 2009 | 2962 | 0.010 |
Why?
|
| Comorbidity | 1 | 2010 | 10388 | 0.010 |
Why?
|
| T-Lymphocytes, Regulatory | 1 | 2009 | 2988 | 0.010 |
Why?
|
| Signal Transduction | 1 | 2018 | 23404 | 0.010 |
Why?
|
| Pulmonary Disease, Chronic Obstructive | 1 | 2009 | 3047 | 0.010 |
Why?
|
| Aged | 2 | 2012 | 163288 | 0.000 |
Why?
|
| Aged, 80 and over | 1 | 2012 | 57776 | 0.000 |
Why?
|
| Middle Aged | 2 | 2012 | 213390 | 0.000 |
Why?
|
| Animals | 1 | 1996 | 168768 | 0.000 |
Why?
|